Senior insider sale
President and CEO at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$2.36M
34.60K shares
What this filing means
AZAMIAN BOBAK R. plans to sell 34.60K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $2.36M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/19/2026ACC: 0001959173-26-002519
DirectorOfficer10% Owner· President and CEO
Since Oct 2020
34.60K
Shares to sell
$2.36M
Approx. market value
11.96K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/18/2026
11.96KTotal acquired11.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/18/2026 | Restricted Stock Vesting Compensation | 11.96K | — |
| Total | 11.96K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
11.67K
Market value
$801.6K
3/18/2026
—Completed
Units to sell
10.97K
Market value
$761.6K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.96K
Market value
$801.6K
3/19/2026
Total
Units
34.60K
Value
$2.36M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/18/2026 | 11.67K | $801.6K | — | Completed |
3/17/2026 | 10.97K | $761.6K | — | Completed |
| Planned — Approximate Date | ||||
3/19/2026 | 11.96K | $801.6K | NASDAQ | Planned |
| Total | 34.60K | $2.36M | ||